The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The association between PSA pattern changes and progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC) treated with abiraterone and prednisone (AA/P).
 
Iris Yeong- Fung Sheng
No Relationships to Disclose
 
Jaleh Fallah
No Relationships to Disclose
 
Ruby Gupta
No Relationships to Disclose
 
Hong Li
No Relationships to Disclose
 
Kimberly D. Allman
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - Amgen; Exelixis
 
Allison Martin
No Relationships to Disclose
 
Pedro C. Barata
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Caris Life Sciences; Eisai; EMD Serono; Pfizer
Research Funding - Blue Earth Diagnostics (Inst)
 
Moshe Chaim Ornstein
Consulting or Advisory Role - Eisai; Exelixis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis
 
Timothy D. Gilligan
Travel, Accommodations, Expenses - Dendreon
 
Brian I. Rini
Leadership - MJH Life Sciences
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Merck; Peloton Therapeutics; Pfizer; Roche/Genentech; Surface Oncology; synthorx
Research Funding - AstraZeneca/MedImmune (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Pfizer
 
Jorge A. Garcia
Consulting or Advisory Role - Bayer; Clovis Oncology; Eisai; Sanofi; Targeted Oncology
Speakers' Bureau - Bayer; Merck; Sanofi; Sanofi/Aventis
Research Funding - Genentech/Roche (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (I); Orion (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Clovis Oncology; Eisai; Janssen; Medivation/Astellas; Merck; Sanofi